Canada Markets closed
  • S&P/TSX

    19,222.74
    -35.58 (-0.18%)
     
  • S&P 500

    3,821.55
    -78.56 (-2.01%)
     
  • DOW

    30,946.99
    -491.27 (-1.56%)
     
  • CAD/USD

    0.7766
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    111.67
    +2.10 (+1.92%)
     
  • BTC-CAD

    26,067.17
    -981.79 (-3.63%)
     
  • CMC Crypto 200

    440.29
    -9.77 (-2.17%)
     
  • GOLD FUTURES

    1,820.80
    -4.00 (-0.22%)
     
  • RUSSELL 2000

    1,740.74
    -31.00 (-1.75%)
     
  • 10-Yr Bond

    3.2060
    +0.0120 (+0.38%)
     
  • NASDAQ

    11,181.54
    -343.01 (-2.98%)
     
  • VOLATILITY

    28.26
    +1.31 (+4.86%)
     
  • FTSE

    7,323.41
    +65.09 (+0.90%)
     
  • NIKKEI 225

    27,049.47
    +178.20 (+0.66%)
     
  • CAD/EUR

    0.7376
    +0.0040 (+0.55%)
     

ELEVAI IS PLEASED TO ANNOUNCE IT HAS WON THE PEOPLES CHOICE AWARD AT THE 2022 OCTANE AESTHETICS TECH SUMMIT

·2 min read

DAVIS, Calif., Jan. 25, 2022 /CNW/ -- ELEVAI LABS, INC., ("ELEVAI" or the "Company") a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that the company has won the LaunchPad SBDC People's Choice Award at the 2022 Octane Aesthetics Tech Summit ("ATS") held in Newport Beach, California.

Elevai Labs Inc. (PRNewsfoto/Elevai Labs Inc.)
Elevai Labs Inc. (PRNewsfoto/Elevai Labs Inc.)

Co-Founder and CEO, Jordan R. Plews, PhD, and his team were invited to present at this two-day event attended by hundreds of leaders in medicine, the aesthetic industry, and the business world to discuss innovative medical aesthetic technologies, as well as unmet clinical needs and new business opportunities.

Dr. Plews is quoted saying "ELEVAI is honored to receive this year's people's choice award. Our company is grateful the aesthetic community is recognizing the team's hard work, dedication to excellence, and our innovative skincare technology as an up-and-coming leader in the space. We look forward to sharing the ELEVAI E-Series post procedure products globally with the professional aesthetics community."

Octane recently recognized ELEVAI as a top medical aesthetics innovator and selected the company for their LaunchPad Small Business Development Center ("SBDC") business accelerator, a rigorous program developed to help companies seeking Series A funding.

The Aesthetics Tech Summit featured ELEVAI along with other aesthetics start-up companies that are part of the LaunchPad program and are raising a combined total of $50 million. The Summit is sponsored by Allergan Aesthetics, an AbbVie company.

About ELEVAI Labs

ELEVAI Labs, Inc. is a biotechnology company developing cutting-edge regenerative skincare applications. The company solves the unmet needs in the regenerative aesthetics space through a combination of cutting-edge science and next-generation consumer applications. Elevai Labs, Inc. develops state-of-the-art topical aesthetic skincare products for the physician-dispensed market, with a focus on leveraging stem cell exosome technology. Learn more about Elevai Labs, Inc. at www.elevaiskincare.com.

For further information: Kendra Ciardiello, Associate Director, contact@elevailabs.com, 1-866-794-4940

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/elevai-is-pleased-to-announce-it-has-won-the-peoples-choice-award-at-the-2022-octane-aesthetics-tech-summit-301468220.html

SOURCE Elevai Labs Inc.

Cision
Cision

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/25/c2503.html

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting